| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3289455 | Gastroenterología y Hepatología | 2006 | 6 Pages |
Abstract
Although their efficacy has been questioned, nonabsorbable disaccharides and protein restriction are the most commonly prescribed treatments for hepatic encephalopathy. Future studies are needed to assess the efficacy and risks of these treatments. Most hepatologists never assess minimal hepatic encephalopathy in patients with cirrhosis.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
M. Vergara-Gómez, M. Flavià -Olivella, M. Gil-Prades, B. Dalmau-Obrador, J. Córdoba-Cardona,